*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
Cynthia Sundell, Ph.D. - Senior Director of Life Sciences, IBB
Harold Solomon - Principal, GT VentureLab
Summary Sentence: "A Venn Diagram of Science, Medicine, Finance, and Business Management" - Jack Krieger, Ph.D. - BridgeBio
Full Summary: No summary paragraph submitted.
Petit Entrepreneurship Academy SeminarHelping GT entrepreneurs learn how to fund and commercialize their technology.
"A Venn Diagram of Science, Medicine, Finance, and Business Management"
Jack Krieger, Ph.D.
Director, Portfolio Intelligence
BridgeBio
REGISTER HERE - participation link to be provided upon submission
AGENDA
11:00 a.m. Seminar
Noon-12:30 p.m. Extended "Office Hours" discussion
ABSTRACT
Bringing biomedical technologies to patients at scale requires not just deep subject matter expertise, but also “hybrid” capabilities that straddle multiple disciplines. In this session I’ll share my reflections from biotech on what “interdisciplinary” means in the pharmaceutical and medical product ecosystem.
BIO
In his role in portfolio intelligence, Jack Krieger develops and delivers recommendations for executive leadership on capital allocation, R&D strategy, and competitive intelligence across the BridgeBio's portfolio of genetic disease medicines. He has business development experience, leading the diligence of an indication expansion opportunity.
Krieger also co-leads with a cross-functional team the scientific strategy and operations of the preclinical program for autism spectrum disorder associated with PTEN gene variants.
The series is hosted by the Parker H. Petit Institute for Bioengineering and Bioscience and GT's VentureLab. For inquiries or suggestions about future seminars, contact Cynthia Sundell, Senior Director of Life Sciences, IBB, or Harold Solomon, Principal, VentureLab.
